Table 1 Pharmacokinetic parameters of CIN in healthy controls and individuals with mild, moderate and severe renal impairment, showing values as geometric mean (coefficient of variation, %) except for fu which is expressed as arithmetic mean (standard deviation).

From: Pharmacokinetic analysis of the soluble guanylate cyclase activator cinaciguat (BAY 58-2667) in individuals with renal impairment compared to healthy controls